Meridian Bioscience Inc. (VIVO)
NASDAQ: VIVO
· Real-Time Price · USD
33.97
0.00 (0.00%)
At close: Jan 30, 2023, 10:00 PM
Meridian Bioscience Revenue Breakdown
| Period Ending | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | Sep 30, 2015 | Sep 30, 2014 | Sep 30, 2013 | Sep 30, 2012 | Sep 30, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostics Revenue | 155.9M | 127.76M | 121.13M | 136.68M | 150.45M | 143.52M | 145.11M | 334K | 432K | 144.63M | 1.1M | 756K |
| Diagnostics Revenue Growth | +22.03% | +5.47% | -11.38% | -9.15% | +4.83% | -1.10% | +43347.31% | -22.69% | -99.70% | +13084.05% | +45.11% | n/a |
| Life Science Revenue | 177.12M | 190.14M | 132.53M | 64.33M | 63.12M | 57.25M | 50.97M | 1.3M | 1.01M | 44.06M | n/a | n/a |
| Life Science Revenue Growth | -6.85% | +43.46% | +106.02% | +1.92% | +10.25% | +12.33% | +3820.62% | +28.84% | -97.71% | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Sep 30, 2017 | Sep 30, 2016 | Sep 30, 2015 | Sep 30, 2014 | Sep 30, 2013 | Sep 30, 2012 | Sep 30, 2011 |
|---|---|---|---|---|---|---|---|
| Belgium Revenue | 1.56M | 1.5M | 1.29M | 8.47M | 9.58M | 1.27M | 3.1M |
| Belgium Revenue Growth | +4.00% | +16.45% | -84.78% | -11.61% | +653.82% | -59.07% | n/a |
| France Revenue | 2.74M | 2.17M | 2.03M | n/a | n/a | 1.28M | 2.54M |
| France Revenue Growth | +26.40% | +6.96% | n/a | n/a | n/a | -49.47% | n/a |
| Italy Revenue | 6.54M | 6.6M | 7.09M | n/a | n/a | 7.47M | 4.92M |
| Italy Revenue Growth | -0.89% | -6.93% | n/a | n/a | n/a | +51.83% | n/a |
| Japan Revenue | 1.37M | 1.32M | 2.6M | n/a | n/a | 9.9M | 7.3M |
| Japan Revenue Growth | +3.71% | -49.29% | n/a | n/a | n/a | +35.57% | n/a |
| Netherlands Revenue | 1.24M | 1.19M | 1.33M | n/a | n/a | 3.42M | 15.71M |
| Netherlands Revenue Growth | +4.38% | -10.41% | n/a | n/a | n/a | -78.21% | n/a |
| Other Countries Revenue | 6.22M | 6.89M | 7.59M | n/a | n/a | 4.87M | 1.29M |
| Other Countries Revenue Growth | -9.77% | -9.26% | n/a | n/a | n/a | +277.97% | n/a |
| United States Revenue | 20.49M | 19.96M | 21.92M | n/a | n/a | 17.8M | 8.54M |
| United States Revenue Growth | +2.64% | -8.91% | n/a | n/a | n/a | +108.39% | n/a |
| Australia Revenue | 4M | 3.15M | 3.59M | n/a | n/a | n/a | n/a |
| Australia Revenue Growth | +26.80% | -12.17% | n/a | n/a | n/a | n/a | n/a |
| China Revenue | 5.86M | 4.08M | 2.11M | n/a | n/a | n/a | n/a |
| China Revenue Growth | +43.68% | +93.64% | n/a | n/a | n/a | n/a | n/a |
| Germany Revenue | 7.27M | 6.98M | 5.7M | n/a | n/a | n/a | n/a |
| Germany Revenue Growth | +4.07% | +22.51% | n/a | n/a | n/a | n/a | n/a |
| Korea (South), Won Revenue | 2.42M | n/a | n/a | n/a | n/a | n/a | n/a |
| Korea (South), Won Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 19.37M | 18.62M | 21.33M | 26.58M | 22.68M | 19.83M | 18.61M | 20.5M | 11.94M | 20.59M | 18.83M | 17.73M | 15.76M | 17.52M | 14.75M | 14.3M | 16.46M | 11.73M | 17.79M | 21.22M | 19.23M | 17.39M | 16.36M | 15.44M | 15.96M | 16.39M | 15.62M | 15.29M | 14.62M | 13.61M | 12.72M | 13.42M |
| Selling, General, and Administrative Revenue Growth | +3.99% | -12.67% | -19.75% | +17.17% | +14.37% | +6.56% | -9.19% | +71.68% | -42.01% | +9.31% | +6.23% | +12.49% | -10.06% | +18.80% | +3.15% | -13.16% | +40.32% | -34.06% | -16.13% | +10.33% | +10.60% | +6.28% | +5.97% | -3.27% | -2.64% | +4.93% | +2.19% | +4.59% | +7.38% | +7.02% | -5.23% | n/a |
| Research and Development Revenue | 6.18M | 6.41M | 6.04M | 5.69M | 6.19M | 6.11M | 6.08M | 6.07M | 5.65M | 6.78M | 6.74M | 5.39M | 4.82M | 5.65M | 4.59M | 3.82M | 3.97M | 3.63M | 4.26M | 4.22M | 4.5M | 4.46M | 3.91M | 3.91M | 3.4M | 3.76M | 3.55M | 3.13M | 3.38M | 2.92M | 3.21M | 3.37M |
| Research and Development Revenue Growth | -3.59% | +6.02% | +6.19% | -8.12% | +1.34% | +0.48% | +0.30% | +7.33% | -16.60% | +0.49% | +25.19% | +11.65% | -14.68% | +23.07% | +20.39% | -3.81% | +9.43% | -14.89% | +0.88% | -6.09% | +0.76% | +14.23% | -0.03% | +14.74% | -9.42% | +6.01% | +13.33% | -7.45% | +15.79% | -9.15% | -4.57% | n/a |
| Sales and Marketing Revenue | 8.29M | 7.84M | 8.18M | 7.51M | 7.74M | 7.01M | 6.21M | 6.54M | 7.02M | 7.03M | 6.26M | 6.51M | 6.68M | 7.22M | 6.75M | 6.91M | 7.56M | 8.51M | 8.5M | 8.65M | 8.84M | 8.69M | 7.88M | 8.01M | 7.51M | 8.13M | 8.09M | 7.21M | 6.44M | 6.86M | 6.18M | 6.48M |
| Sales and Marketing Revenue Growth | +5.79% | -4.13% | +8.84% | -2.93% | +10.43% | +12.90% | -5.06% | -6.85% | -0.09% | +12.23% | -3.88% | -2.54% | -7.49% | +7.08% | -2.37% | -8.62% | -11.09% | +0.02% | -1.67% | -2.19% | +1.75% | +10.21% | -1.59% | +6.63% | -7.61% | +0.59% | +12.14% | +11.90% | -6.02% | +10.87% | -4.58% | n/a |